Joinn Laboratories' (HKG:6127, SHA:603127) attributable profit fell 58% year over year to 99.4 million yuan in the third quarter, according to a Wednesday filing with the Hong Kong Exchange.
Earnings per share at the pharmacology and toxicology research company decreased 59% year over year to 0.13 yuan.
Operating income declined 16% year over year to 485.8 million yuan.
Shares fell 1% during Friday's trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.